-
Credit Acceptance Announces Completion of $500.0 Million Asset-Backed Financing
28 Mar 2024 20:02 GMT
… (Nasdaq: CACC) (the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today … is publicly traded on the Nasdaq stock market under the symbol CACC …
-
16 Most Profitable Tech Stocks To Invest In
28 Mar 2024 19:18 GMT
… that movements in their share prices could end up … stocks, we used hedge fund sentiment. Hedge funds’ top 10 consensus stock … made a notable AI announcement in March 2024 when … price. NVIDIA Corporation (NASDAQ:NVDA)’s shares are nevertheless rated Strong …
-
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
28 Mar 2024 20:15 GMT
… NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive … , 2024, in Long Beach, California.
Announced that multiple presentations will be …
Common stock, $0.001 par value per share – 200,000,000 shares authorized …
-
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
28 Mar 2024 20:05 GMT
… ) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical … and diagnostic products, announces financial results for the … artificial insemination, Femasys announced completion of enrollment in …
11,987
Treasury stock, 117,223 common shares
(60,000
)
(60 …
-
Rail Vision Announces Fourth Quarter and Full Year 2023 Financial Results
28 Mar 2024 22:04 GMT
… NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the … .
In February 2024, Rail Vision announced it has joined NVIDIA Metropolis … , except share data and per share data)
Convertible
Preferred A Shares
Ordinary Shares
Additional …
-
BLUE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead the bluebird bio Class Action Lawsuit
28 Mar 2024 21:55 GMT
… Rudman & Dowd LLP announces that the bluebird bio class … bluebird bio, Inc. (NASDAQ: BLUE) common stock between April 24, 2023 … April 24, 2023, defendants announced submission of its Biologics License … investor’s ability to share in any potential future …
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
28 Mar 2024 20:51 GMT
… -course gene editing medicines, today announced that on March 28, 2024 … of 91,200 shares of the company’s common stock and an … price of $13.28 per share, which is equal to the … Verve Therapeutics
Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage …
-
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of bluebird bio, Inc. Common Stock and Sets a Lead Plaintiff Deadline of May 28, 2024
28 Mar 2024 22:08 GMT
… common stock of bluebird bio, Inc. (“Blue” or the “Company”) (NASDAQ: BLUE … on December 8, 2023, Blue announced that the Food and Drug … Blue’s stock price fell by $1.95 per share, or approximately … lead plaintiff. Your ability to share in any recovery doesn’t …
-
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
28 Mar 2024 20:01 GMT
… fight disease, today announces its financial results for … is a publicly traded (NASDAQ: INMB), clinical-stage … SHEETS
(In thousands, except share and per share amounts)
… shares authorized, 0 shares issued and outstanding
-
-
Common stock …
-
Firsthand Technology Value Fund Announces Fiscal Year Financial Results, NAV of $0.18 Per Share
28 Mar 2024 21:35 GMT
SAN JOSE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, announced today its financial results for the …